24 Hrs_1777294237270_124456903.png&w=64&q=75)
Source:
الوطن
Slimming injections for addiction and mental health
The article discusses the development of research by pharmaceutical companies regarding slimming injections, as these companies are striving to develop inspired medications for use in treating psychological and neurological disorders such as addiction, depression, schizophrenia, and Parkinson's disease. Clinical results, including an experiment with the drug "Semaglutide," have shown a reduction in alcohol cravings and episodes of excessive drinking, which has boosted interest in using these medications to treat addiction. Long-acting drugs like "Brinhibitide" have also been developed to treat brain disorders, and research has expanded to cover a wide range of mental and neurological conditions, with plans for Phase III trials of the drug "BT-001" in early 2027. However, the scientific applications of these drugs are still under study and have not yet received the necessary regulatory approvals.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)